In this section you can find an overview of shareholders holding at least 3% of Fagron shares, the number of shares held by the members of Fagron’s Board of Directors and the number of shares held by the members of Fagron’s Executive Leadership Team.
Article 11 of the articles of association of the company specifies that participations must be notified as soon as a threshold of 3%, 5% and any multiple of 5% has been passed.
The number of Fagron shares with voting rights is 73,773,104. The total number of voting rights (denominator) is 73,773,104.
* in relation to the notifications received from The Goldman Sachs Group, Inc. and NN Group N.V. please read the following document.
Situation as of April 24, 2026, based on notifications received:
|
Number of rights |
% of effective voting rights |
|
|---|---|---|
| The Goldman Sachs Group, Inc.* |
13,209,148 |
17.91% |
| AOC Pharma S.à r.l. |
7,274,291 |
9.86% |
| FMR LLC |
3,019,960 |
4.09% |
| BNP Paribas Asset Management Holding |
2,405,870 |
3.26% |
* This represents the shareholding of Goldman Sachs Group, Inc. including the share held through NN Group N.V. Please read the following document.
The shareholding of Fagron’s Board of Directors, as most recently updated on May 2, 2025, is presented in the table below.
|
Number of shares |
|
|---|---|
| Koen Hoffman | 0 |
| Rafael Padilla |
179,580 |
| Karin de Jong |
40,000 |
| Rob ten Hoedt | 0 |
| Els Vandecandelaere | 0 |
| Ann Desender | 0 |
| Neeraj Sharma | 0 |
| Philipp Klecka |
See the most recent transparency notification |
The shareholding of Fagron’s Executive Leadership Team, as most recently updated on January 9, 2026, is presented in the table below.
|
Number of shares |
|
|---|---|
| Rafael Padilla |
179,580 |
| Karin de Jong |
40,000 |
| Vera Bakker |
655 |
| Andrew Pulido |
20,000 |
| Geraldino Neder |
17,185 |
| Konstantinos (Kostas) Kouloridas |
1,500 |
Shareholding declaration obligation (Transparancy declaration). For practical information and forms, please visit the website of FSMA: www.fsma.be
